Fundraising Fox

Erika Kjellberg Eriksson

Investor

CEO and Chair of the Board at NXT2B

About

Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.

Deals · 9

AllgoHolding ABSolo GP

via NXT2B

Hansa Biopharma ABSolo GP

via NXT2B

Lokon Pharma ABSolo GP

via NXT2B

Lumina Adhesives ABSolo GP

via NXT2B

Navinci Diagnostics ABSolo GP

via NXT2B

Q-linea ABSolo GP

via NXT2B

Repos Pharma ABSolo GP

via NXT2B

Scint-X ABSolo GP

via NXT2B

Vivolux ABSolo GP

via NXT2B

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Colleagues at NXT2B

Angelica Loskog
Scientific adviser at NXT2B
Bengt Ågerup
Senior Adviser at NXT2B
Per-Olof Wallström
Member of the Board at NXT2B